Could targeting oxtyocin help treat opioid addiction?

April 5, 2017, Wiley
Pills. Credit: Public Domain

A new review of published research indicates that the oxytocin system—a key player in social reward and stress regulation—is profoundly affected by opioid use. Therefore, it may be an important target for developing medications to treat opioid addiction and to prevent relapse.

"Social withdrawal is one of the key factors that can predispose people to heroin but is also a consequence of drug use," said Dr. Alexis Bailey, senior author of the British Journal of Pharmacology review.

"Given the benefits that social support programs like Alcoholics Anonymous and Narcotics Anonymous have in keeping addicts abstinent, current findings in the review suggest the use of the prosocial hormone oxytocin as a novel effective 'psycho-biological therapy' for the prevention of relapse to drug-use in drug dependent individuals. Therefore clinical studies assessing the efficacy of oxytocin-based pharmacotherapies in addiction are warranted."

Explore further: Opioid users treated in drug detention centers more likely to relapse

More information: British Journal of Pharmacology (2017). DOI: 10.1111/bph.13757

Related Stories

Opioid users treated in drug detention centers more likely to relapse

December 8, 2016
Individuals who are dependent on opioids are more likely to relapse after treatment in a compulsory drug detention center versus a voluntary drug treatment center that provides methadone therapy, say the Yale authors of a ...

Use of psychosocial treatments in conjunction with medication for opioid addiction—recommended, but research is sparse

January 26, 2016
Psychosocial interventions, used together with effective medications, are a key part of recommended treatment for opioid addiction. But while research generally supports the effectiveness of psychosocial treatments, there ...

Treat patients with addiction during, after hospitalization, researchers say

June 30, 2014
The results of a new study demonstrate that starting hospitalized patients who have an opioid (heroin) addiction on buprenorphine treatment in the hospital and seamlessly connecting them with an outpatient office based treatment ...

Can 'love hormone' oxytocin protect against addiction?

March 19, 2014
(Medical Xpress)—Researchers at the University of Adelaide say addictive behaviour such as drug and alcohol abuse could be associated with poor development of the so-called "love hormone" system in our bodies during early ...

Commercial weight-loss drug could help treat opioid addiction

February 8, 2017
Scientists are working to come up with new therapies to curb America's opioid epidemic and aid hospitals, doctors and public health officials in this fight. Now one team reports in the journal ACS Chemical Neuroscience that ...

Opportunities for addiction care and HIV prevention in Russia

January 23, 2017
Opioid agonist therapy using methadone is regarded as one of the most effective treatments for opioid use disorders as well as helping to reduce HIV risks. Such therapy, however, is not yet available in Russia.

Recommended for you

Common use of antipsychotics shown ineffective for delirium in intensive care patients

October 22, 2018
Critically ill patients in intensive care units (ICUs) did not benefit from two antipsychotic drugs used to treat delirium, according to a large clinical trial funded by the National Institute on Aging, part of the National ...

Medicating distress: Risky sedative prescriptions for older adults vary widely

October 18, 2018
Despite years of warnings that older adults shouldn't take sedative drugs that put them at risk of injury and death, a new study reveals how many primary care doctors are still prescribing them, how often, and exactly where.

Medical management of opioid-induced constipation differs from other forms of condition

October 17, 2018
Traditional laxatives are recommended as first-line agents to treat patients with a confirmed diagnosis of opioid-induced constipation (OIC), according to a new guideline from the American Gastroenterological Association ...

Research assesses geographic distribution of new antibiotics following market introduction

October 16, 2018
There is a growing need for new antibiotics to help combat the looming threat of antimicrobial resistance. According to a new study conducted by researchers at the Center for Disease Dynamics, Economics & Policy (CDDEP) with ...

Health insurer policies may discourage use of non-opioid alternatives for lower back pain

October 5, 2018
Public and private health insurance policies in the U.S. are missing important opportunities to encourage the use of physical therapy, psychological counseling and other non-drug alternatives to opioid medication for treating ...

Opioid overdoses, depression linked

October 3, 2018
The link between mental health disorders and substance abuse is well-documented. Nearly one in 12 adults in the U.S is depressed, and opioid-related deaths are skyrocketing. As these numbers continue to climb, some mental ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.